351 related articles for article (PubMed ID: 17559367)
21. Oral ciprofloxacin versus intravenous cefotaxime and ceftriaxone in the treatment of spontaneous bacterial peritonitis.
Tuncer I; Topcu N; Durmus A; Turkdogan MK
Hepatogastroenterology; 2003; 50(53):1426-30. PubMed ID: 14571754
[TBL] [Abstract][Full Text] [Related]
22. Genetic background of Escherichia coli isolates from patients with spontaneous bacterial peritonitis: relationship with host factors and prognosis.
Bert F; Panhard X; Johnson J; Lecuyer H; Moreau R; Le Grand J; Johnston B; Sinègre M; Valla D; Nicolas-Chanoine MH
Clin Microbiol Infect; 2008 Nov; 14(11):1034-40. PubMed ID: 19040475
[TBL] [Abstract][Full Text] [Related]
23. [Spontaneous bacterial peritonitis- undervalued complication in liver cirrhosis].
Prelipcean CC
Rev Med Chir Soc Med Nat Iasi; 2001; 105(4):682-4. PubMed ID: 12092220
[TBL] [Abstract][Full Text] [Related]
24. Spontaneous bacterial peritonitis before liver transplantation does not affect patient survival.
Mounzer R; Malik SM; Nasr J; Madani B; Devera ME; Ahmad J
Clin Gastroenterol Hepatol; 2010 Jul; 8(7):623-628.e1. PubMed ID: 20417723
[TBL] [Abstract][Full Text] [Related]
25. Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study.
Rimola A; Salmerón JM; Clemente G; Rodrigo L; Obrador A; Miranda ML; Guarner C; Planas R; Solá R; Vargas V
Hepatology; 1995 Mar; 21(3):674-9. PubMed ID: 7875666
[TBL] [Abstract][Full Text] [Related]
26. Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites.
Sandhu BS; Gupta R; Sharma J; Singh J; Murthy NS; Sarin SK
J Gastroenterol Hepatol; 2005 Apr; 20(4):599-605. PubMed ID: 15836710
[TBL] [Abstract][Full Text] [Related]
27. Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis.
Chang CS; Chen GH; Lien HC; Yeh HZ
Hepatology; 1998 Nov; 28(5):1187-90. PubMed ID: 9794900
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and clinical outcome of spontaneous bacterial peritonitis in hospitalized patients with liver cirrhosis: a prospective observational study in central part of Croatia.
Gunjaca I; Francetić I
Acta Clin Croat; 2010 Mar; 49(1):11-8. PubMed ID: 20635579
[TBL] [Abstract][Full Text] [Related]
29. Effects of pentoxifylline on intestinal bacterial overgrowth, bacterial translocation and spontaneous bacterial peritonitis in cirrhotic rats with ascites.
Corradi F; Brusasco C; Fernández J; Vila J; Ramirez MJ; Seva-Pereira T; Fernández-Varo G; Mosbah IB; Acevedo J; Silva A; Rocco PR; Pelosi P; Gines P; Navasa M
Dig Liver Dis; 2012 Mar; 44(3):239-44. PubMed ID: 22119621
[TBL] [Abstract][Full Text] [Related]
30. [Bacterial infections in liver cirrhosis].
Papp M; Farkas A; Udvardy M; Tornai I
Orv Hetil; 2007 Mar; 148(9):387-95. PubMed ID: 17344166
[TBL] [Abstract][Full Text] [Related]
31. The efficacy and the immunomodulatory effect of rifaximin in prophylaxis of spontaneous bacterial peritonitis in cirrhotic Egyptian patients.
Mostafa T; Badra G; Abdallah M
Turk J Gastroenterol; 2015 Mar; 26(2):163-9. PubMed ID: 25835116
[TBL] [Abstract][Full Text] [Related]
32. Association between model for end-stage liver disease and spontaneous bacterial peritonitis.
Obstein KL; Campbell MS; Reddy KR; Yang YX
Am J Gastroenterol; 2007 Dec; 102(12):2732-6. PubMed ID: 17714556
[TBL] [Abstract][Full Text] [Related]
33. Long-term prophylaxis of spontaneous bacterial peritonitis in patients with cirrhosis.
Frazee LA; Marinos AE; Rybarczyk AM; Fulton SA
Ann Pharmacother; 2005 May; 39(5):908-12. PubMed ID: 15769829
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: a prospective randomized open-label comparative multicenter study.
Assem M; Elsabaawy M; Abdelrashed M; Elemam S; Khodeer S; Hamed W; Abdelaziz A; El-Azab G
Hepatol Int; 2016 Mar; 10(2):377-85. PubMed ID: 26660707
[TBL] [Abstract][Full Text] [Related]
35. Effect of long-term trimethoprim-sulfamethoxazole prophylaxis on ascites formation, bacterial translocation, spontaneous bacterial peritonitis, and survival in cirrhotic rats.
Guarner C; Runyon BA; Heck M; Young S; Sheikh MY
Dig Dis Sci; 1999 Oct; 44(10):1957-62. PubMed ID: 10548343
[TBL] [Abstract][Full Text] [Related]
36. Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis.
Chen TA; Tsao YC; Chen A; Lo GH; Lin CK; Yu HC; Cheng LC; Hsu PI; Tsai WL
Scand J Gastroenterol; 2009; 44(5):619-25. PubMed ID: 19191184
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis, treatment and prevention of spontaneous bacterial peritonitis.
Fernández J; Bauer TM; Navasa M; Rodés J
Baillieres Best Pract Res Clin Gastroenterol; 2000 Dec; 14(6):975-990. PubMed ID: 11139350
[TBL] [Abstract][Full Text] [Related]
38. Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study.
Arredondo-García JL; Figueroa-Damián R; Rosas A; Jáuregui A; Corral M; Costa A; Merlos RM; Ríos-Fabra A; Amábile-Cuevas CF; Hernández-Oliva GM; Olguín J; Cardeñosa-Guerra O;
J Antimicrob Chemother; 2004 Oct; 54(4):840-3. PubMed ID: 15347634
[TBL] [Abstract][Full Text] [Related]
39. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Fernández J; Navasa M; Gómez J; Colmenero J; Vila J; Arroyo V; Rodés J
Hepatology; 2002 Jan; 35(1):140-8. PubMed ID: 11786970
[TBL] [Abstract][Full Text] [Related]
40. Randomized trial of weekly sulfadoxine/pyrimethamine vs. daily low-dose trimethoprim-sulfamethoxazole for the prophylaxis of Pneumocystis carinii pneumonia after liver transplantation.
Torre-Cisneros J; De la Mata M; Pozo JC; Serrano P; Briceño J; Solórzano G; Miño G; Pera C; Sánchez-Guijo P
Clin Infect Dis; 1999 Oct; 29(4):771-4. PubMed ID: 10589886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
